Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-05-06 Sale |
2024-05-07 4:56 pm |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
3,576 | $1.13 | $4,041 | 1,153,697 (Direct) |
View |
| 2024-04-22 Sale |
2024-04-23 4:02 pm |
Karyopharm Therapeutics Inc. | KPTI | Rangwala Reshma EVP & Chief Medical Officer |
6,789 | $1.17 | $7,943 | 342,931 (Direct) |
View |
| 2024-04-04 Sale |
2024-04-05 5:20 pm |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
3,563 | $1.29 | $4,596 | 1,157,273 (Direct) |
View |
| 2024-03-05 Sale |
2024-03-06 4:14 pm |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
3,573 | $1.3 | $4,645 | 1,160,836 (Direct) |
View |
| 2024-02-29 Sale |
2024-03-04 7:41 pm |
Karyopharm Therapeutics Inc. | KPTI | Rangwala Reshma EVP & Chief Medical Officer |
21,636 | $1.1783 | $25,493 | 349,720 (Direct) |
View |
| 2024-02-29 Sale |
2024-03-04 7:40 pm |
Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer |
22,466 | $1.1782 | $26,470 | 329,511 (Direct) |
View |
| 2024-02-29 Sale |
2024-03-04 7:39 pm |
Karyopharm Therapeutics Inc. | KPTI | Mason Michael EVP, CFO & Treasurer |
33,849 | $1.1755 | $39,788 | 398,756 (Direct) |
View |
| 2024-02-29 Sale |
2024-03-04 7:38 pm |
Karyopharm Therapeutics Inc. | KPTI | Mano Michael SVP, General Counsel&Secretary |
20,549 | $1.1752 | $24,150 | 277,852 (Direct) |
View |
| 2024-02-29 Sale |
2024-03-04 7:37 pm |
Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer |
26,949 | $1.1757 | $31,684 | 393,509 (Direct) |
View |
| 2024-02-29 Sale |
2024-03-04 7:36 pm |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
99,844 | $1.1758 | $117,399 | 1,164,409 (Direct) |
View |
| 2024-02-27 Sale |
2024-02-29 5:35 pm |
Karyopharm Therapeutics Inc. | KPTI | Mason Michael EVP, CFO & Treasurer |
2,545 | $1.3238 | $3,369 | 432,605 (Direct) |
View |
| 2024-02-15 Sale |
2024-02-20 4:59 pm |
Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer |
5,847 | $1.3312 | $7,783 | 163,772 (Direct) |
View |
| 2024-02-06 Sale |
2024-02-08 4:36 pm |
Karyopharm Therapeutics Inc. | KPTI | Mason Michael EVP, CFO & Treasurer |
4,205 | $1.5865 | $6,671 | 246,945 (Direct) |
View |
| 2024-02-06 Sale |
2024-02-08 4:34 pm |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
4,012 | $1.5865 | $6,365 | 821,453 (Direct) |
View |
| 2024-01-04 Sale |
2024-01-08 9:00 pm |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
4,114 | $0.82 | $3,373 | 783,465 (Direct) |
View |
| 2023-12-04 Sale |
2023-12-05 5:03 pm |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
3,622 | $0.79 | $2,861 | 787,579 (Direct) |
View |
| 2023-11-06 Sale |
2023-11-07 5:32 pm |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
3,606 | $0.9203 | $3,319 | 791,201 (Direct) |
View |
| 2023-10-04 Sale |
2023-10-05 4:46 pm |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
3,589 | $1.27 | $4,558 | 794,807 (Direct) |
View |
| 2023-09-12 Purchase |
2023-09-12 4:07 pm |
Karyopharm Therapeutics Inc. | KPTI | BOHLIN GAREN G Director |
41,140 | $1.215 | $49,985 | 45,140 (Direct) |
View |
| 2023-09-05 Sale |
2023-09-06 4:06 pm |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
3,622 | $1.3298 | $4,817 | 798,396 (Direct) |
View |
| 2023-09-01 Sale |
2023-09-05 4:30 pm |
Karyopharm Therapeutics Inc. | KPTI | Mason Michael EVP, CFO & Treasurer |
6,913 | $1.3313 | $9,203 | 237,817 (Direct) |
View |
| 2023-09-01 Sale |
2023-09-05 4:29 pm |
Karyopharm Therapeutics Inc. | KPTI | Mano Michael SVP, General Counsel&Secretary |
3,888 | $1.3313 | $5,176 | 142,234 (Direct) |
View |
| 2023-09-01 Sale |
2023-09-05 4:27 pm |
Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer |
7,415 | $1.3313 | $9,872 | 204,086 (Direct) |
View |
| 2023-08-07 Sale |
2023-08-08 5:02 pm |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
3,722 | $1.72 | $6,402 | 802,018 (Direct) |
View |
| 2023-07-28 Sale |
2023-08-01 5:37 pm |
Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer |
2,845 | $1.7 | $4,837 | 156,286 (Direct) |
View |
| 2023-07-05 Sale |
2023-07-06 5:36 pm |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
3,538 | $1.72 | $6,085 | 805,740 (Direct) |
View |
| 2023-06-08 Sale |
2023-06-12 4:07 pm |
Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer |
1,839 | $2.35 | $4,322 | 211,501 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-28 Option Award |
2024-02-29 5:36 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Rangwala Reshma EVP & Chief Medical Officer |
198,959 | $0 | 371,356 (Direct) |
View |
| 2024-02-28 Option Award |
2024-02-29 5:35 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer |
188,205 | $0 | 351,977 (Direct) |
View |
| 2024-02-28 Option Award |
2024-02-29 5:35 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Mason Michael EVP, CFO & Treasurer |
188,205 | $0 | 432,605 (Direct) |
View |
| 2024-02-28 Option Award |
2024-02-29 5:35 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Mano Michael SVP, General Counsel&Secretary |
147,000 | $0 | 298,401 (Direct) |
View |
| 2024-02-28 Option Award |
2024-02-29 5:35 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer |
198,959 | $0 | 420,458 (Direct) |
View |
| 2024-02-28 Option Award |
2024-02-29 5:34 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
442,800 | $0 | 1,264,253 (Direct) |
View |
| 2024-01-24 Option Award |
2024-01-25 7:40 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan EVP & Chief Commercial Officer |
14,167 | $0 | 221,499 (Direct) |
View |
| 2024-01-24 Option Award |
2024-01-25 7:16 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Rangwala Reshma EVP & Chief Medical Officer |
14,167 | $0 | 172,397 (Direct) |
View |
| 2024-01-24 Option Award |
2024-01-25 7:14 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Poulton Stuart EVP, Chief Development Officer |
13,333 | $0 | 169,619 (Direct) |
View |
| 2024-01-24 Option Award |
2024-01-25 6:53 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Mano Michael SVP, General Counsel&Secretary |
9,167 | $0 | 151,401 (Direct) |
View |
| 2024-01-24 Option Award |
2024-01-25 6:47 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Mason Michael EVP, CFO & Treasurer |
13,333 | $0 | 251,150 (Direct) |
View |
| 2024-01-24 Option Award |
2024-01-25 6:43 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
42,000 | $0 | 825,465 (Direct) |
View |
| 2023-08-31 Option Award |
2023-09-01 08:20 am |
N/A 2033-08-30 |
Karyopharm Therapeutics Inc. | KPTI | Su Zhen Director |
68,000 | $0 | 68,000 (Direct) |
View |